Developed with funding from the United States Department of Defense, ARAI is a next-generation auto-injector that addresses the shortfalls of the current auto-injector market.

Developed to exceed the highest standards of the military, ARAI helps protect the U.S. armed forces from exposure to unconventional threats. As such, our platform is designed for use by minimally trained personnel, allows superior drug stability, and is rugged enough to withstand even the most extreme field conditions.

ARAI also appeals to the United States Department of Health and Human Services for homeland security applications. Its uses pertain to the protection of the U.S. population from accidental or hostile exposure to certain poisons, such as nerve gas.

AktiVax is currently under government contracts to develop:

  • Atropine
  • 2-PAM
  • Naloxone
  • Nalmefene
  • Sopolamine
  • MMB4
 
ARAI Family.jpeg

(Quote from Someone) 

“Etiam tristique posuere sapien at mattis. Praesent feugiat pulvinar justo id varius. Fusce nisl elit, dictum eget condimentum eu, elementum sed ante. Vestibulum ante ipsum primis in faucibus orci luctus.”

— L.K.